An6'ctober.^907[m"}    American  Pharmaceutical  Association.  469 
The  report  of  the  Nominating  Committee  was  accepted  and  the 
following  officers  for  the  ensuing  year  were  duly  elected  :  President, 
William  M.  Searby,  San  Francisco;  first  vice-president,  Oscar  Old- 
berg,  Chicago;  second  vice-president,  H.  H.  Rusby,  New  York; 
third  vice-president,  O.  W.  Bethea,  Meridian,  Miss.;  treasurer,  S. 
A.  D.  Sheppard,  Boston  ;  general  secretary,  Charles  Caspari,  Jr., 
Baltimore  ;  reporter  on  the  Progress  of  Pharmacy,  C.  Lewis  Diehl, 
Louisville;  new  members  of  Council:  Leo  Eliel,  South  Bend,  Ind.; 
E.  G.  Eberle,  Dallas,  Tex,;  and  F.  C.  Godbold,  New  Orleans. 
For  honorary  president  the  association  unanimously  elected  P. 
C.  Candidus,  of  Mobile. 
The  report  of  the  treasurer,  S.  A.  D.  Sheppard,  for  the  fiscal  year, 
July  1,  1906,  to  July  I,  1907,  showed  that  the  receipts,  not  includ- 
ing money  for  funds,  were  $19,507.49,  and  the  expenses,  $14,661.69, 
the  receipts  thus  exceeding  the  expenses  by  $4,845.80. 
After  presenting  his  report,  Mr.  Sheppard  announced  that  he 
would  retire  from  office  next  year,  thus  giving  the  Association  a 
year  to  consider  the  question  of  his  successor. 
Secretary  Caspari  read  a  report  covering  the  work  of  the  Com- 
mittee on  Publication,  which  contained  the  statement  that  the 
unprecedented  number  of  24,000  copies  of  the  National  Formulary 
had  been  printed  during  the  past  year. 
In  his  report  as  editor  of  the  American  Pharmaceutical  Associa- 
tion Bulletin,  C.  S.  N.  Hallberg  stated  that  40,000  copies  of  the 
convention  number  of  the  Bulletin  had  been  distributed. 
Chairman  A.  B.  Lyons,  of  the  Committee  on  the  United  States 
Pharmacopoeia,  being  absent,  the  report  of  the  committee  was  read 
by  E.  Fullerton  Cook,  of  Philadelphia. 
A  report  which  Prof.  Joseph  P.  Remington  had  presented  as  chair- 
man of  the  Revision  Committee  to  the  Board  of  Trustees  of  the 
United  States  Pharmacopoeia,  at  a  meeting  held  on  the  Friday 
previous,  was  also  submitted  at  the  suggestion  of  the  latter  body. 
In  this  report  Professor  Remington  referred  briefly  to  the  discussion 
in  one  of  the  drug  journals  upon  the  subject  of  "  Government 
Revision,"  and  said  that  "  while  the  replies  which  have  been  sent 
to  the  journal  have  not  been  sufficient  to  warrant  the  expression  of 
a  definite  opinion,  it  would  seem  that  a  majority  of  the  writers  are 
not  favorable  to  a  change  in  the  general  plan." 
In  this  connection  he  quoted  from  the  address  of  the  president 
